Cancer Core Europe: A translational research infrastructure for a European mission on cancer
暂无分享,去创建一个
C. Caldas | G. Apolone | I. Ernberg | A. Eggermont | J. Tabernero | E. Voest | U. Ringborg | J. Celis | F. Calvo | Michael Baumann | John Rowell | F. de Lorenzo | F. De Lorenzo
[1] C. Caldas,et al. Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century. , 2018, European journal of cancer.
[2] A. Gavin,et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. , 2018, European journal of cancer.
[3] D. Forman,et al. Time for a European initiative for research to prevent cancer: A manifesto for Cancer Prevention Europe (CPE) , 2018, Journal of Cancer Policy.
[4] E. Birney,et al. A roadmap for restoring trust in Big Data. , 2018, The Lancet Oncology.
[5] S. Stearns,et al. The transition to modernity and chronic disease: mismatch and natural selection , 2018, Nature Reviews Genetics.
[6] A. Berns,et al. European Academy of Cancer Sciences-Designation of Comprehensive Cancer Centres of Excellence. , 2018, European Journal of Cancer.
[7] J. Celis,et al. A mission‐oriented approach to cancer in Europe: a joint mission/vision 2030 , 2017, Molecular oncology.
[8] B. Jönsson,et al. The cost and burden of cancer in the European Union 1995-2014. , 2016, European journal of cancer.
[9] R. Sullivan,et al. ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] C. Caldas,et al. Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge. , 2014, European journal of cancer.
[11] Richard Sullivan,et al. Economic burden of cancer across the European Union: a population-based cost analysis. , 2013, The Lancet. Oncology.
[12] Karol Sikora,et al. Delivering affordable cancer care in high-income countries. , 2011, The Lancet. Oncology.